Biotech industry finds a friend in Jay Inslee – Seattle Times

In the run-up to passage of the national health-care law in 2010, Congress was fighting over an obscure provision with billions of dollars at stake: how quickly to allow generic versions of costly new biotech drugs. The biotech industry mounted ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>